These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1169 related items for PubMed ID: 10908538

  • 1. Bromocriptine versus levodopa in early Parkinson's disease.
    Ramaker C, van Hilten JJ.
    Cochrane Database Syst Rev; 2000; (3):CD002258. PubMed ID: 10908538
    [Abstract] [Full Text] [Related]

  • 2. Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease.
    Ramaker C, Hilten JJ.
    Cochrane Database Syst Rev; 2002; (2):CD003634. PubMed ID: 12076493
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease.
    van Hilten JJ, Ramaker CC, Stowe R, Ives NJ.
    Cochrane Database Syst Rev; 2007 Oct 17; 2007(4):CD003634. PubMed ID: 17943795
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The efficacy and safety of adjunct bromocriptine therapy for levodopa-induced motor complications: a systematic review.
    Ramaker C, van de Beek WJ, Finken MJ, van Hilten BJ.
    Mov Disord; 2000 Jan 17; 15(1):56-64. PubMed ID: 10634242
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease.
    Clarke CE, Deane KD.
    Cochrane Database Syst Rev; 2001 Jan 17; 2001(1):CD001519. PubMed ID: 11279721
    [Abstract] [Full Text] [Related]

  • 9. Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
    Clarke CE, Deane KH.
    Cochrane Database Syst Rev; 2000 Jan 17; 2001(3):CD001517. PubMed ID: 10908504
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pergolide versus bromocriptine for levodopa-induced motor complications in Parkinson's disease.
    Clarke C E, Speller J M.
    Cochrane Database Syst Rev; 2000 Jan 17; (2):CD000236. PubMed ID: 10796705
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Early combination therapy with bromocriptine and levodopa in Parkinson's disease.
    Factor SA, Weiner WJ.
    Mov Disord; 1993 Jul 17; 8(3):257-62. PubMed ID: 8341289
    [Abstract] [Full Text] [Related]

  • 18. Cabergoline for levodopa-induced complications in Parkinson's disease.
    Clarke CE, Deane KH.
    Cochrane Database Syst Rev; 2001 Jul 17; 2001(1):CD001518. PubMed ID: 11279720
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Early combination therapy (bromocriptine and levodopa) does not prevent motor fluctuations in Parkinson's disease.
    Weiner WJ, Factor SA, Sanchez-Ramos JR, Singer C, Sheldon C, Cornelius L, Ingenito A.
    Neurology; 1993 Jan 17; 43(1):21-7. PubMed ID: 8423888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.